FGF23 and secondary hyperparathyroidism: Some researchers have accordingly hypothesized that inhibition of the activity of the parathyroid FGF23/αKlotho axis by judicious selection and overexpression of specific microRNAs may be an effective strategy for the treatment of secondary hyperparathyroidism.